NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OmniBRx Biotechnologies

OmniBRx Biotechnologies

Private
Ahmedabad, GujaratHealthcare & Life Scienceshttps://www.omnibrx.com/

Last Round

Series A

Mar 13, 2023

Total Funding Raised

$3.71M

Company Overview

OmniBRx Biotechnologies is a biotechnology company that provides upstream bioprocessing solutions, including the design, development, and manufacturing of single-use bioreactor platforms for cell culture applications such as vaccines, viral vectors, and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

single-use bioreactorsSUBupstream bioprocessingadherent cell culturebioprocessing equipmentviral vector manufacturingvaccine manufacturingcell and gene therapyCGT manufacturingscalable biomanufacturingcontract manufacturingCMO servicesCDMO servicescGMP manufacturingDynamic Bed ReactorDBR technologybiologics production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OmniBRx Biotechnologies Comparables

Compare OmniBRx Biotechnologies with similar companies based on industry and business-model similarity.

OmniBRx Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PBS Biotech
80%
Donaldson Company
79%
Esco Lifesciences Group
78%

OmniBRx Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 13, 2023
GrantMay 15, 2019

Key People

Founding team and executive leadership

Ravindra Patel

Chief Technology Officer

Executive Team

OmniBRx Biotechnologies Investors

Notable investors and investment history

OmniBRx Biotechnologies investors
InvestorRounds
Biotechnology Industry Research Assistance CouncilSeed, Grant
Venture CenterSeed
SIDBI Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2025

    Monthly visitors increased 48% MoM.

  • Jan 15, 2025

    Monthly visitors increased 389% MoM.

OmniBRx Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OmniBRx Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OmniBRx Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersAhmedabad, Gujarat
Employee Range24
Year Founded2016
Last FundingMar 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.